Abstract:
:Wittes and Brittain recommended using an 'internal pilot study' to adjust sample size. The approach involves five steps in testing a general linear hypothesis for a general linear univariate model, with Gaussian errors. First, specify the design, hypothesis, desired test size, power, a smallest 'clinically meaningful' effect, and a speculated error variance. Second, conduct a power analysis to choose provisionally a planned sample size. Third, collect a specified proportion of the planned sample as the internal pilot sample, and estimate the variance (but do not test the hypothesis). Fourth, update the power analysis with the variance estimate to adjust the total sample size. Fifth, finish the study and test the hypothesis with all data. We describe methods for computing exact test size and power under this scenario. Our analytic results agree with simulations of Wittes and Brittain. Furthermore, our exact results apply to any general linear univariate model with fixed predictors, which is much more general than the two-sample t-test considered by Wittes and Brittain. In addition, our results allow for examination of the impact on test size of internal pilot studies for more complicated designs in the framework of the general linear model. We examine the impact of (i) small samples, (ii) allowing the planned sample size to decrease, (iii) the choice of internal pilot sample size, and (iv) the maximum allowable size of the second sample. All affect test size, power and expected total sample size. We present a number of examples including one that uses an internal pilot study in a three-group analysis of variance.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Coffey CS,Muller KEdoi
10.1002/(sici)1097-0258(19990530)18:10<1199::aid-ssubject
Has Abstractpub_date
1999-05-30 00:00:00pages
1199-214issue
10eissn
0277-6715issn
1097-0258pii
10.1002/(SICI)1097-0258(19990530)18:10<1199::AID-Sjournal_volume
18pub_type
杂志文章abstract::The identification of counties burdened by exceptionally high rates of mortality is a fundamental step in the development of state-based intervention and prevention strategies. However, the estimation of rates from small geographic areas presents special problems, especially for rare events. This paper compares the us...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780120320
更新日期:1993-02-01 00:00:00
abstract::We propose a new design for dose finding for cytotoxic agents in two ordered groups of patients. By ordered groups, we mean that prior to the study there is clinical information that would indicate that for a given dose one group would be more susceptible to toxicities than patients in the other group. The designs are...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7133
更新日期:2017-01-30 00:00:00
abstract::Previous work on the consequences of regression to the mean for the interpretation of responses to treatment is extended to the situation where the response measured is the proportional change in some variable. Methods for correcting for the bias are discussed. ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780060203
更新日期:1987-03-01 00:00:00
abstract::Joint models initially dedicated to a single longitudinal marker and a single time-to-event need to be extended to account for the rich longitudinal data of cohort studies. Multiple causes of clinical progression are indeed usually observed, and multiple longitudinal markers are collected when the true latent trait of...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6731
更新日期:2016-02-10 00:00:00
abstract::The analysis of patient-reported outcomes or other psychological traits can be realized using the Rasch measurement model. When the objective of a study is to compare groups of individuals, it is important, before the study, to define a sample size such that the group comparison test will attain a given power. The Ras...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6478
更新日期:2015-07-20 00:00:00
abstract::In many community-based studies on the incidence of dementia, a target population is screened and a subsample is clinically evaluated at baseline and follow-up. Incidence rates are affected by missed cases at both exams and this complicates the estimation of these rates. Recent work proposes a regression-based techniq...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(20000615/30)19:11/12<1577:
更新日期:2000-06-15 00:00:00
abstract::We extend the method proposed in a recent work by the Authors for trial-level general surrogate evaluation to allow combinations of biomarkers and provide a procedure for finding the "best" combination of biomarkers based on the absolute prediction error summary of surrogate quality. We use a nonparametric Bayesian mo...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7996
更新日期:2019-03-30 00:00:00
abstract::Statistical methods are available for performing a meta-analysis when the response variable of interest is the same in each study. Problems arise when studies exploring a common therapeutic question use different patient response types. This article presents statistical methods for combining studies which involve diff...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780132313
更新日期:1994-12-15 00:00:00
abstract::Disease incidence or disease mortality rates for small areas are often displayed on maps. Maps of raw rates, disease counts divided by the total population at risk, have been criticized as unreliable due to non-constant variance associated with heterogeneity in base population size. This has led to the use of model-ba...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/1097-0258(20000915/30)19:17/18<2377::aid-s
更新日期:2000-09-15 00:00:00
abstract::The goal of phase I cancer trials is to determine the highest dose of a treatment regimen with an acceptable toxicity rate. Traditional designs for phase I trials, such as the Continual Reassessment Method (CRM) and the 3 + 3 design, require each patient or a cohort of patients to be fully evaluated for the dose-limit...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4255
更新日期:2011-07-30 00:00:00
abstract::Surrogate endpoint validation has been well established by the meta-analytical correlation-based approach as outlined in the seminal work of Buyse et al. (Biostatistics, 2000). Surrogacy can be assumed if strong associations on individual and study levels can be demonstrated. Alternatively, if an effect on a true endp...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6778
更新日期:2016-03-30 00:00:00
abstract::In the recent two decades, data mining methods for signal detection have been developed for drug safety surveillance, using large post-market safety data. Several of these methods assume that the number of reports for each drug-adverse event combination is a Poisson random variable with mean proportional to the unknow...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6510
更新日期:2015-08-30 00:00:00
abstract::Although population-based molecular association studies are becoming increasingly popular, methodology for the meta-analysis of these studies has been neglected, particularly with regard to two issues: testing Hardy-Weinberg equilibrium (HWE), and pooling results in a manner that reflects a biological model of gene ef...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2010
更新日期:2005-05-15 00:00:00
abstract::In many biomedical and epidemiological studies, data are often clustered due to longitudinal follow up or repeated sampling. While in some clustered data the cluster size is pre-determined, in others it may be correlated with the outcome of subunits, resulting in informative cluster size. When the cluster size is info...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4239
更新日期:2011-07-10 00:00:00
abstract::Hierarchical regression analysis holds much promise for epidemiologic analysis, but has as yet seen limited application because of lack of easily used software and the relatively lengthy run times of preferred fitting methods (such as true maximum likelihood and Bayesian approaches). This paper compares three relative...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19970315)16:5<515::aid-sim
更新日期:1997-03-15 00:00:00
abstract::Relative survival is used to estimate patient survival excluding causes of death not related to the disease of interest. Rather than using cause of death information from death certificates, which is often poorly recorded, relative survival compares the observed survival to that expected in a matched group from the ge...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2399
更新日期:2005-12-30 00:00:00
abstract::This paper investigates the impact on area life tables of the specification of unobserved frailty. Frailty specification may affect both the regression effects of area and individual level covariates, and lead to changes in the value of summary mortality parameters, such as life expectancy. The paper also investigates...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780141703
更新日期:1995-09-15 00:00:00
abstract::Graphical methods based on the analysis of differences between log cumulative hazard functions are considered for a two-group semi-proportional hazard model which allows for interaction between treatments and covariates. Confidence procedures and test statistics that can be used to test for interaction and for main ef...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780111105
更新日期:1992-08-01 00:00:00
abstract::The sample size required for a cluster randomised trial is inflated compared with an individually randomised trial because outcomes of participants from the same cluster are correlated. Sample size calculations for longitudinal cluster randomised trials (including stepped wedge trials) need to take account of at least...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7028
更新日期:2016-11-20 00:00:00
abstract::Girardeau, Ravaud and Donner in 2008 presented a formula for sample size calculations for cluster randomised crossover trials, when the intracluster correlation coefficient, interperiod correlation coefficient and mean cluster size are specified in advance. However, in many randomised trials, the number of clusters is...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8191
更新日期:2019-08-15 00:00:00
abstract::We consider several sources of heterogeneity in a clinical trial with patients' survival time as the main response criterion: differences in prognosis which can be attributed to a latent or ignored prognostic factor; differences in treatment efficacy in subgroups of patients, and differences in treatment combinations ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780060708
更新日期:1987-10-01 00:00:00
abstract::A statistical definition of surrogate endpoints as well as validation criteria was first presented by Prentice. Freedman et al. supplemented these criteria with the so-called proportion explained. Buyse and Molenberghs pointed to inadequacies of these criteria and suggested a new definition of surrogacy based on (i) t...
journal_title:Statistics in medicine
pub_type: 评论,杂志文章
doi:10.1002/sim.923
更新日期:2001-10-30 00:00:00
abstract::The validity and practical utility of observational medical research depends critically on good study design, excellent data quality, appropriate statistical methods and accurate interpretation of results. Statistical methodology has seen substantial development in recent times. Unfortunately, many of these methodolog...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6265
更新日期:2014-12-30 00:00:00
abstract::The statistical analysis of spatially correlated data has become an important scientific research topic lately. The analysis of the mortality or morbidity rates observed at different areas may help to decide if people living in certain locations are considered at higher risk than others. Once the statistical model for...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/1097-0258(20000730)19:14<1915::aid-sim503>
更新日期:2000-07-30 00:00:00
abstract::Patient reported outcome and observer evaluative studies in clinical trials and post-hoc analyses often use instruments that measure responses on ordinal-rating or Likert scales. We propose a flexible distributional approach by modeling the change scores from the baseline to the end of the study using independent beta...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4012
更新日期:2010-10-30 00:00:00
abstract::Multilevel and longitudinal studies are frequently subject to missing data. For example, biomarker studies for oral cancer may involve multiple assays for each participant. Assays may fail, resulting in missing data values that can be assumed to be missing completely at random. Catellier and Muller proposed a data ana...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6811
更新日期:2016-07-30 00:00:00
abstract::Although all clinical trials are designed and monitored using more than one endpoint, methods are needed to assure that decision criteria are chosen to reflect the clinically relevant tradeoffs that assure the trial's scientific integrity. This article presents a framework for the design and monitoring clinical trials...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8696
更新日期:2020-11-20 00:00:00
abstract::Important differences between explanatory and pragmatic studies were originally argued by Schwartz and Lellouch. Three important differences between the two types of study involve study control, study violators and inclusion criteria. It was originally argued that explanatory studies are highly controlled, and pragmat...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1120
更新日期:2002-05-30 00:00:00
abstract::We develop parametric maximum likelihood methods to adjust for treatment changes during follow-up in order to assess the causal effect of treatment in clinical trials with time-to-event outcomes. The accelerated failure time model of Robins and Tsiatis relates each observed event time to the underlying event time that...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1618
更新日期:2004-02-28 00:00:00
abstract::Mediation analysis is a standard approach to understanding how and why an intervention works in social and medical sciences. However, the presence of missing data, especially missing not at random data, poses a great challenge for the applicability of this approach in practice. Current methods for handling such missin...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7413
更新日期:2017-11-10 00:00:00